Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and effectiveness of Upadacitinib tablets in adults and adolescents with severe alopecia areata, and the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Alopecia Areata | Phase 3 | Status: RECRUITING